Galmed Pharma Files 6-K with Q1 2025 Financials
Ticker: GLMD · Form: 6-K · Filed: May 22, 2025 · CIK: 1595353
| Field | Detail |
|---|---|
| Company | Galmed Pharmaceuticals LTD. (GLMD) |
| Form Type | 6-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-report, quarterly-results, sec-filing
TL;DR
Galmed Pharma dropped its Q1 2025 financials in a 6-K filing.
AI Summary
Galmed Pharmaceuticals Ltd. filed a Form 6-K on May 22, 2025, reporting its unaudited condensed consolidated financial statements for the three months ended March 31, 2025. The filing also includes related information and other disclosures as required for a foreign private issuer. The company is incorporated in L3 and its fiscal year ends on December 31.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Galmed Pharmaceuticals Ltd., crucial for assessing the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine financial disclosure and does not contain significant new risks or material events.
Key Numbers
- Q1 2025 — Financial Period (Unaudited condensed consolidated financial statements for the three months ended March 31, 2025.)
Key Players & Entities
- Galmed Pharmaceuticals Ltd. (company) — Registrant
- 0001595353 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- 97236938448 (dollar_amount) — Business Phone Number
- May 22, 2025 (date) — Filing Date
- March 31, 2025 (date) — End of Financial Period
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K contains the quarterly report of Galmed Pharmaceuticals Ltd., including its unaudited condensed consolidated financial statements for the three months ended March 31, 2025, together with related information and certain other information.
When was this filing submitted to the SEC?
This filing was submitted on May 22, 2025.
What is Galmed Pharmaceuticals Ltd.'s fiscal year end?
Galmed Pharmaceuticals Ltd.'s fiscal year ends on December 31.
What is the company's SIC code and industry?
The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Is Galmed Pharmaceuticals Ltd. required to file quarterly reports under Section 13 or 15(d) of the Securities Exchange Act of 1934?
No, the company states it is not subject to the requirements to file quarterly or certain other reports under Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 22, 2025 regarding Galmed Pharmaceuticals Ltd. (GLMD).